A pharmacological characterization of Cannabis sativa chemovar extracts

Table 2 The concentrations of Δ⁹-THC and CBD derived from each cannabis cultivar extract

Cultivar Sample	Cannabinoid Concentration (mg/ml)
Cultivar Sample	Δ⁹-THC	CBD	CBC	CBG	CBDV	CBDA	CBN	THCV	THCA	CBDVA	CBGA	Max dose Δ⁹-THC administered (mg/kg)	Max dose CBD administered (mg/kg)
CTL-H01.H3^c	7.54	0.02	0.17	0.20	–	a	0.07	0.06	0.69	–	–	3	0.01
CTL-H01.H2	3.23	a	0.06	0.10	a	a	0.06	0.13	a	–	a	6	a
CTL-P01.H1	1.98	4.52	0.31	0.02	0.03	0.09	a	a	a	a	b	6	13.7
CTL-G01.H8	0.50	6.52	1.39	0.04	0.07	0.93	0.06	a	a	a	b	3	39.1
CTL-G03.H2	0.72	5.49	0.72	a	0.01	0.77	a	b	a	a	b	3	22.9
CTL-X02.H1	0.45	2.91	0.37	0.107	0.09	1.31	0.041	0.05	0.77	–	–	2	12.9

(−) indicates cannabinoid was not determined in the preparation
^abLOQ Below level of quantification for the cultivar assay range (0.977–500 ng Δ⁹-THC/mL). Refers to the limit at which the difference between two distinct values can be distinguished using the assay
^bbLOD Below level of detection for cultivar assay range for all cultivars. The lowest quantity of the extract component distinguished from the absence of that substance (i.e., blank value) with a confidence level of 99%
^cIndicates sample was re-tested
CBDVA Cannabidivarin acid, CBDV Cannabidivarin, CBDA Cannabidiolic Acid, CBG Cannabigerol, CBD Cannabidiol, THCV Δ⁹-Tetrahydrocannabivarin, CBN Cannabinol, Δ⁹-THC Δ⁹-tetrahydrocannabinol (Δ⁹-THC), CBC Cannabichomene, THCA Δ⁹-Tetrahydrocannabinolic acid

ISSN: 2522-5782